Back

Proteogenomic mapping of multimorbidity identifies C1R linking coronary artery disease and dementia

Li, L.; Tang, Z.; Zhong, Z.; Geng, T.; Guo, Y.; Liao, Y.; Demirkan, A.; Bowden, J.; Bragg, F.; Pan, A.; Sun, X.; Liu, J.; Liu, G.; Liu, J.

2026-07-16 genetic and genomic medicine
10.64898/2026.07.14.26358022 medRxiv
Show abstract

Multimorbidity is highly prevalent in ageing populations, yet its shared molecular basis remains poorly defined, limiting the development of therapies that target multiple conditions. We systematically integrated measurements of 1,954 circulating proteins from 54,219 individuals in discovery and 35,559 in replication, focusing on ten common age-related diseases: coronary artery disease, chronic kidney disease, chronic obstructive pulmonary disease, dementia, heart failure, major depressive disorder, osteoarthritis, Parkinson's disease, stroke, and type 2 diabetes. Coronary artery disease emerged as a central condition in the multimorbidity network, sharing circulating protein signatures with seven other diseases. Through genetic causal-inference analyses, we identified 40 circulating proteins with cross-disease relevance, of which four were further supported by colocalization of genetic variant associations. Among these, complement C1r, encoded by C1R, emerged as a key link between coronary artery disease and dementia, supported by independent colocalization evidence (PP.H4 = 0.86). Phenome-wide association analyses of C1R variants suggested that this signal was not driven by widespread unrelated genetic effects, but instead may reflect a more specific contribution to coronary artery disease-dementia pathogenesis. In vitro experiments further suggested that fibroblast-derived C1R promotes endothelial inflammation and neuronal apoptosis, providing mechanistic plausibility. Together, these findings position C1R as a biologically plausible and therapeutically relevant molecular link between coronary artery disease and dementia.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Nature Aging
60 papers in training set
Top 0.1%
41.6%
2
Nature Communications
5641 papers in training set
Top 13%
13.6%
50% of probability mass above
3
Aging Cell
165 papers in training set
Top 0.5%
8.3%
4
Genome Medicine
183 papers in training set
Top 2%
2.8%
5
Cell Metabolism
57 papers in training set
Top 0.6%
2.0%
6
eLife
5828 papers in training set
Top 45%
2.0%
7
eBioMedicine
183 papers in training set
Top 2%
1.8%
8
Nature Metabolism
69 papers in training set
Top 1%
1.8%
9
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 27%
1.8%
10
Nature
645 papers in training set
Top 7%
1.6%
11
npj Aging
22 papers in training set
Top 0.3%
1.6%
12
Molecular Neurodegeneration
55 papers in training set
Top 1%
1.4%
13
Nature Medicine
125 papers in training set
Top 2%
1.4%
14
Nature Genetics
286 papers in training set
Top 4%
1.1%
15
Developmental Cell
196 papers in training set
Top 3%
1.1%
16
Cell Reports
1498 papers in training set
Top 24%
1.1%
17
Communications Biology
993 papers in training set
Top 28%
0.9%
18
GeroScience
109 papers in training set
Top 2%
0.9%
19
Cell
431 papers in training set
Top 11%
0.6%
20
Science
477 papers in training set
Top 9%
0.6%
21
Journal of Clinical Investigation
179 papers in training set
Top 7%
0.5%
22
Circulation: Genomic and Precision Medicine
48 papers in training set
Top 1%
0.5%
23
Nature Neuroscience
252 papers in training set
Top 6%
0.5%
24
Scientific Reports
3612 papers in training set
Top 81%
0.5%
25
The Journals of Gerontology: Series A
29 papers in training set
Top 0.7%
0.5%
26
Alzheimer's & Dementia
163 papers in training set
Top 2%
0.5%
27
Science Advances
1243 papers in training set
Top 35%
0.5%